01 1Cadila Pharmaceuticals
01 1AMLODIPINE BESYLATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-19
Pay. Date : 2013-06-07
DMF Number : 16911
Submission : 2003-09-13
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AMLODIPINE BESYLATE USP, with a corresponding US DMF Number 16911.
Remarkably, this DMF maintains an Active status since its submission on September 13, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 19, 2013, and payment made on June 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
